Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001831900-22-000001
Filing Date
2022-12-01
Accepted
2022-11-30 21:31:34
Documents
1
Effectiveness Date
2022-12-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9500
  Complete submission text file 0001831900-22-000001.txt   10572
Mailing Address 300 EAST 33RD STREET APT 14 M NEW YORK NY 10016
Business Address 300 EAST 33RD STREET APT 14 M NEW YORK NY 10016 212-308-6000
Equilibre BioPharmaceuticals Corp. (Filer) CIK: 0001831900 (see all company filings)

EIN.: 853484646 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-466233 | Film No.: 221437136